HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sandip Basu Selected Research

gallium Ga 68 dotatate

2/2022False positive 68Ga-DOTATATE PET-CT in Hereditary hypophosphatemic-osteomalacia mimicking culprit lesions of tumor induced osteomalacia.
12/2021Differential tumor biology between locoregional and distant metastasis in a patient with TENIS with TKI-resistant aggressive recurrent disease: a comparative evaluation with FDG, 68Ga-DOTATATE and 68Ga-PSMA-11 PET-CT.
3/2021Poorly Differentiated Neuroendocrine Carcinoma of the Parotid Gland and Moderately Differentiated Hepatic Metastases: A Discordant Histopathology Clarified by Dual-Tracer PET/CT.
1/2021Grade 3 metastatic neuroendocrine neoplasms of two unusual primary sites with contrasting differentiation characteristics: Dual tracer positron emission tomography and computed tomography imaging (18F-fluorodeoxyglucose and 68Ga-DOTATATE) correlates and their treatment implications.
10/2020Interpreting discordance on dual-tracer positron emission tomography-computed tomography in the setting of metastatic neuroendocrine tumor: Detection of metachronous triple-negative breast carcinoma.
10/2020Standardized uptake values and ratios on 68Ga-DOTATATE PET-computed tomography for normal organs and malignant lesions and their correlation with Krenning score in patients with metastatic neuroendocrine tumors.
9/2020Occurrence of the Redifferentiation-Akin Phenomenon on 68Ga-DOTATATE PET/CT After CAPTEM Chemotherapy in Metastatic Neuroendocrine Tumors with Intermediate MIB1 Index: What Could Be the Molecular Explanation?
6/2019Bilateral Orbital Soft-Tissue Metastases from Renal Neuroendocrine Tumor: Successful Theranostic Application of 68Ga/177Lu-DOTATATE with Improvement of Vision.
4/2019Prevalence of hitherto unknown brain meningioma detected on 68Ga-DOTATATE positron-emission tomography/computed tomography in patients with metastatic neuroendocrine tumor and exploring potential of 177Lu-DOTATATE peptide receptor radionuclide therapy as single-shot treatment approach targeting both tumors.
1/2017Metabolic Bone Disease in the Context of Metastatic Neuroendocrine Tumor: Differentiation from Skeletal Metastasis, the Molecular PET-CT Imaging Features, and Exploring the Possible Etiopathologies Including Parathyroid Adenoma (MEN1) and Paraneoplastic Humoral Hypercalcemia of Malignancy Due to PTHrP Hypersecretion.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sandip Basu Research Topics

Disease

74Neoplasms (Cancer)
10/2022 - 09/2005
39Neoplasm Metastasis (Metastasis)
10/2022 - 04/2007
36Neuroendocrine Tumors (Neuroendocrine Tumor)
10/2022 - 12/2014
25Thyroid Neoplasms (Thyroid Cancer)
04/2022 - 08/2007
12Breast Neoplasms (Breast Cancer)
07/2022 - 08/2007
11Carcinoma (Carcinomatosis)
03/2022 - 09/2009
9Infections
07/2022 - 01/2009
7Disease Progression
10/2019 - 09/2015
6Adenocarcinoma
03/2022 - 09/2012
6Prostatic Neoplasms (Prostate Cancer)
03/2022 - 12/2018
6Medullary Carcinoma
01/2020 - 09/2006
6Inflammation (Inflammations)
07/2016 - 03/2009
4Diabetic Foot
07/2022 - 06/2007
4Pain (Aches)
10/2021 - 10/2015
4Lung Diseases (Lung Disease)
07/2016 - 11/2007
4Papillary Thyroid Cancer
01/2016 - 01/2011
4Osteomyelitis
06/2010 - 06/2007
3Paraganglioma (Paragangliomas)
01/2021 - 12/2011
3Neuroendocrine Carcinoma
01/2021 - 07/2013
3Necrosis
01/2020 - 11/2011
3Hypoxia (Hypoxemia)
01/2019 - 11/2009
3Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
04/2018 - 12/2008
3Acquired Immunodeficiency Syndrome (AIDS)
01/2017 - 01/2008
3Atherosclerosis
07/2016 - 05/2012
3Body Weight (Weight, Body)
10/2015 - 09/2005
3Fever (Fevers)
07/2015 - 05/2009
3Brain Neoplasms (Brain Tumor)
07/2013 - 11/2009
3Osteosarcoma (Osteogenic Sarcoma)
10/2012 - 01/2009
2Osteomalacia
02/2022 - 12/2016
2Bone Diseases (Bone Disease)
02/2022 - 08/2013
2Abdominal Pain (Pain, Abdominal)
01/2021 - 06/2019
2Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2019 - 06/2008
2Chronic Obstructive Pulmonary Disease (COPD)
05/2019 - 11/2007
2Solitary Kidney
01/2018 - 06/2016
2Hyperthyroidism
12/2017 - 01/2016
2Multiple Endocrine Neoplasia Type 1
04/2017 - 01/2017
2Cushing Syndrome
04/2017 - 03/2005
2Lymphadenopathy
03/2017 - 09/2005
2Carcinoid Tumor (Carcinoid)
01/2017 - 12/2011
2Papillary Carcinoma
12/2016 - 07/2014
2Tuberculosis (Tuberculoses)
09/2014 - 10/2009
2Cardiotoxicity
09/2014 - 05/2012
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2014 - 07/2013
2Lung Neoplasms (Lung Cancer)
07/2013 - 01/2010

Drug/Important Bio-Agent (IBA)

40Radioisotopes (Radionuclides)IBA
10/2022 - 01/2012
38Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
04/2022 - 03/2005
36Peptide Receptors (Peptide Receptor)IBA
10/2022 - 06/2014
23lutetium Lu 177 dotatateIBA
09/2022 - 12/2014
19Somatostatin Receptors (Somatostatin Receptor)IBA
10/2022 - 05/2009
16ThyroglobulinFDA Link
12/2021 - 05/2009
15gallium Ga 68 dotatateIBA
02/2022 - 01/2016
13IodineIBA
12/2021 - 08/2007
9Glucose (Dextrose)FDA LinkGeneric
07/2022 - 08/2007
9Fluorine-18IBA
10/2016 - 03/2008
81,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
04/2022 - 07/2014
6AntigensIBA
03/2022 - 01/2017
5Hormones (Hormone)IBA
07/2022 - 10/2015
5Tumor Biomarkers (Tumor Markers)IBA
10/2018 - 12/2013
5Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
10/2015 - 01/2013
5Biomarkers (Surrogate Marker)IBA
09/2014 - 11/2007
4Thyroxine (Levothyroxine)FDA LinkGeneric
04/2022 - 01/2013
4gallium 68 PSMA-11IBA
03/2022 - 04/2021
4177Lu-PSMA-617IBA
11/2021 - 12/2019
4RadiopharmaceuticalsIBA
10/2021 - 09/2017
4Calcitonin (Calcitonin, Eel)FDA LinkGeneric
01/2017 - 01/2011
3Tyrosine Kinase InhibitorsIBA
12/2021 - 06/2016
3DOTA(0)-Tyr(3)-Thr(8)- 90Y-octreotateIBA
03/2021 - 09/2020
3Capecitabine (Xeloda)FDA Link
01/2021 - 05/2011
3Chromogranin AIBA
06/2019 - 06/2014
3Imatinib Mesylate (Gleevec)FDA Link
04/2018 - 12/2008
3Estrogen ReceptorsIBA
04/2018 - 08/2007
3LithiumIBA
12/2017 - 01/2016
3Parathyroid Hormone-Related ProteinIBA
01/2017 - 09/2015
3FluoridesIBA
08/2013 - 05/2011
2LutetiumIBA
04/2022 - 01/2016
23-Iodobenzylguanidine (Iobenguane)IBA
01/2021 - 12/2011
2PlatinumIBA
09/2020 - 04/2018
2Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
10/2019 - 08/2007
2Biological ProductsIBA
03/2019 - 11/2009
2fluoromisonidazoleIBA
01/2019 - 11/2009
2Iodine-131IBA
01/2017 - 05/2016
2Technetium Tc 99m Sestamibi (Cardiolite)FDA LinkGeneric
10/2016 - 05/2009
2Adrenal Cortex Hormones (Corticosteroids)IBA
09/2016 - 10/2009
2Amino AcidsFDA Link
10/2015 - 11/2009
2IntegrinsIBA
09/2015 - 09/2015
2Polyurethanes (Polyurethane)IBA
09/2015 - 09/2015
2Deoxyglucose (2 Deoxy D glucose)IBA
07/2015 - 07/2011
2AntibodiesIBA
10/2014 - 03/2009
2Colloids (Colloid)IBA
07/2014 - 08/2009

Therapy/Procedure

83Therapeutics
10/2022 - 08/2006
15Drug Therapy (Chemotherapy)
03/2021 - 06/2008
12Radiotherapy
01/2021 - 08/2006
9Precision Medicine
05/2021 - 10/2015
6Castration
03/2022 - 12/2018
5Thyroidectomy
03/2017 - 09/2011
5Prostheses and Implants (Prosthesis)
07/2014 - 01/2008
4Contraindications
09/2018 - 06/2010
4Neoadjuvant Therapy
10/2012 - 02/2009
2Arthroplasty
07/2022 - 04/2012
2Radioimmunotherapy
12/2019 - 06/2008